Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer
对信迪利单抗联合吉西他滨和顺铂作为晚期胆道癌一线治疗方案的临床和生物标志物进行分析
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-023-37030-w
Zeng, Tian-Mei; Yang, Guang; Lou, Cheng; Wei, Wei; Tao, Chen-Jie; Chen, Xi-Yun; Han, Qin; Cheng, Zhuo; Shang, Pei-Pei; Dong, Yu-Long; Xu, He-Ming; Guo, Lie-Ping; Chen, Dong-Sheng; Song, Yun-Jie; Qi, Chuang; Deng, Wang-Long; Yuan, Zhen-Gang